A case of an unreported point mutation in promoter 1B of the adenomatous polyposis coli gene, which is responsible for gastric adenocarcinoma and proximal polyposis of the stomach.
Ayaka IshidaYasuhiro InokuchiMakoto HirataHiroto NarimatsuEmi YoshiokaKota WashimiNozomu MachidaShin MaedaPublished in: Clinical journal of gastroenterology (2024)
A 35-year-old woman of Asian descent with epigastralgia was referred to our hospital. Esophagogastroduodenoscopy revealed gastric cancer in the upper body and carpeting fundic gland polyposis in the fornix and body. Computed tomography revealed no metastases. Total colonoscopy and capsule endoscopy revealed no polyposis, except in the stomach. The patient was diagnosed with advanced gastric cancer and underwent open total gastrectomy. We speculated that her gastric cancer was a hereditary tumor due to its early onset and accompanying fundic gland polyposis. Germline multi-gene panel testing identified a single-nucleotide variant, c.-191 T > G, in exon 1B of the adenomatous polyposis coli gene, which can cause gastric adenocarcinoma and proximal polyposis of the stomach. To our knowledge, this is the first manuscript to report the variant (c.-191 T > G) in promoter 1B of the adenomatous polyposis coli gene, which is related to a predisposition to gastric adenocarcinoma and proximal polyposis of the stomach.
Keyphrases
- chronic rhinosinusitis
- early onset
- computed tomography
- escherichia coli
- genome wide
- copy number
- squamous cell carcinoma
- dna methylation
- healthcare
- gene expression
- single cell
- transcription factor
- genome wide identification
- locally advanced
- radiation therapy
- positron emission tomography
- dna damage
- oxidative stress
- adverse drug
- rectal cancer
- genome wide analysis
- dual energy